Alternative splicing within the human cytochrome P450 superfamily with an emphasis on the brain: the convolution continues

被引:17
作者
Turman, Cheri M.
Hatley, Jade M.
Ryder, Daniel J.
Ravindranath, Vijayalakshmi
Strobel, Hen W.
机构
[1] Univ Texas, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA
[2] Natl Brain Res Ctr, Manesar, Haryana, India
关键词
alternative splicing; brain CYPs; cytochrome P450; drug metabolism;
D O I
10.1517/17425255.2.3.399
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human cytochrome P450 (CYP) superfamily of enzymes regulate hepatic phase 1 drug metabolism and subsequently play a significant role in pharmacokinetics, drug discovery and drug development. Alternative splicing of the cytochrome CYP gene transcripts enhances gene diversity and may play a role in transcriptional regulation of certain CYP proteins. Tissue-specific alternative splicing of CYPs is significant for its potential to add greater dimension to differential drug metabolism in hepatic and extrahepatic tissues, such as the brain, and to our understanding of the CYP family. This review provides an overview of tissue-specific splicing patterns, splicing types, regulation and the functional diversities between liver and splice variant CYP proteins and further explores the relevance of tissue-specific alternative splicing of CYPs in the nervous system.
引用
收藏
页码:399 / 418
页数:20
相关论文
共 50 条
  • [31] Roles of human cytochrome P450 enzymes involved in drug metabolism and toxicological studies
    Yamazaki, H
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2000, 120 (12): : 1347 - 1357
  • [32] Toxicological consequences of differential regulation of cytochrome p450 Isoforms in rat brain regions by phenobarbital
    Upadhya, SC
    Chinta, SJ
    Pai, HV
    Boyd, MR
    Ravindranath, V
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2002, 399 (01) : 56 - 65
  • [33] Expression, purification, and biochemical characterization of a human cytochrome P450CYP2D6-NADPH cytochrome P450 reductase fusion protein
    Deeni, YY
    Paine, MJI
    Ayrton, AD
    Clarke, SE
    Chenery, R
    Wolf, CR
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2001, 396 (01) : 16 - 24
  • [34] The impact of porous silicon nanoparticles on human cytochrome P450 metabolism in human liver microsomes in vitro
    Ollikainen, Elisa
    Liu, Dongfei
    Kallio, Arttu
    Makila, Ermei
    Zhang, Hongbo
    Salonen, Jarno
    Santos, Helder A.
    Sikanen, Tiina M.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 104 : 124 - 132
  • [35] Post-translational and Post-transcriptional Modifications of Pregnane X Receptor (PXR) in Regulation of the Cytochrome P450 Superfamily
    Smutny, Tomas
    Mani, Sridhar
    Pavek, Petr
    CURRENT DRUG METABOLISM, 2013, 14 (10) : 1059 - 1069
  • [36] Metabolic interactions of rosmarinic acid with human cytochrome P450 monooxygenases and uridine diphosphate glucuronosyltransferases
    Kim, Sang-Bum
    Kim, Kyu-Sang
    Kim, Dae-Duk
    Yoon, In-Soo
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 110 : 111 - 117
  • [37] Identification and in silico prediction of metabolites of tebufenozide derivatives by major human cytochrome P450 isoforms
    Edamatsu, Hiroaki
    Yagawa, Masataka
    Ikushiro, Shinichi
    Sakaki, Toshiyuki
    Nakagawa, Yoshiaki
    Miyagawa, Hisashi
    Akamatsu, Miki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2020, 28 (09)
  • [38] Genetic analysis of the human cytochrome P450 CYP2C9 locus
    Stubbins, MJ
    Harries, LW
    Smith, G
    Tarbit, MH
    Wolf, CR
    PHARMACOGENETICS, 1996, 6 (05): : 429 - 439
  • [39] Structural basis for regiospecific midazolam oxidation by human cytochrome P450 3A4
    Sevrioukova, Irina F.
    Poulos, Thomas L.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (03) : 486 - 491
  • [40] Development of new Coumarin-based profluorescent substrates for human cytochrome P450 enzymes
    Juvonen, Risto O.
    Ahinko, Mira
    Huuskonen, Juhani
    Raunio, Hannu
    Pentikainen, Olli T.
    XENOBIOTICA, 2019, 49 (09) : 1015 - 1024